What is the Prognosis for Patients with Stromal Tumors?
The prognosis for patients with stromal tumors depends on various factors, including the tumor's size, location, and genetic profile, as well as the patient's overall health. Early detection and effective treatment significantly improve the prognosis. For instance, patients with localized GISTs have a five-year survival rate of approximately 90%, whereas those with metastatic disease have a considerably lower survival rate. The introduction of targeted therapies has markedly improved outcomes for many patients.
